Journal
Cell Reports Medicine
Publication Date
7-16-2024
Volume
5
Issue
7
First Page
101655
Document Type
Open Access Publication
DOI
10.1016/j.xcrm.2024.101655
Rights and Permissions
Amanna IJ, Thomas A, Engelmann F, Hammarlund E, Raué HP, Bailey AL, Poore EA, Quintel BK, Lewis AD, Axthelm MK, Johnson AL, Colgin LMA, Diamond MS, Messaoudi I, Slifka MK. Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model. Cell Rep Med. 2024 Jul 16;5(7):101655. doi: 10.1016/j.xcrm.2024.101655. Copyright 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Amanna, Ian J; Thomas, Archana; Engelmann, Flora; Hammarlund, Erika; Raué, Hans-Peter; Bailey, Adam L; Poore, Elizabeth A; Quintel, Benjamin K; Lewis, Anne D; Axthelm, Michael K; Johnson, Amanda L; Colgin, Lois M A; Diamond, Michael S; Messaoudi, Ilhem; and Slifka, Mark K, "Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model." Cell Reports Medicine. 5, 7. 101655 (2024).
https://digitalcommons.wustl.edu/oa_4/5223
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
